Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon

Armand Garioud , Ratmony Heng , Xavier Amiot (1) , André-Jean Rémy (2) , Isabelle Ollivier-Hourmand (3) , Camélia Mokhtari (4) , Mourad Medmoun , Christophe Renou (5) , Honoré Zougmoré , Philippe Pulwermacher , Damien Lucidarme (6) , Isabelle Rosa-Hézode , Xavier Causse (7) , Ramuntcho Arotcarena , David Zanditenas , Philippe Halfon (8, 9) , Alexandre Pariente (10) , Jean-François Cadranel (11)

1 CHU Tenon [AP-HP]
2 Service de hépato-gastro-entérologie - cancérologie digestive [CH de Perpignan]
3 Service d’Hépato-Gastroentérologie [CHU Angers]
4 Hôpital Paul Brousse
5 Hepatology
6 Service d'hépato-gastro-entérologie
7 CHRO - Centre Hospitalier Régional d'Orléans
8 Hôpital Européen [Fondation Ambroise Paré - Marseille]
9 MEPHI - Microbes évolution phylogénie et infections
10 Centre hospitalier de Pau
11 Service d'Hépato-Gastro-Entérologie

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Armand Garioud, Ratmony Heng, Xavier Amiot, André-Jean Rémy, Isabelle Ollivier-Hourmand, et al.. Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon. European Journal of Gastroenterology & Hepatology, 2019, 31 (10), pp.1270-1274. ⟨10.1097/MEG.0000000000001450⟩. ⟨hal-02512554⟩